Staphylococcus Aureus Bacteremia Antibiotic Treatment Options (SABATO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01792804

Recruitment Status : Recruiting

First Posted : February 15, 2013

Last Update Posted : March 2, 2018

See Contacts and Locations

Sponsor:

Collaborator:

German Research Foundation

Information provided by (Responsible Party):

Heinrich-Heine University, Duesseldorf

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Recruiting
Estimated Primary Completion Date :	October 2018
Estimated Study Completion Date :	October 2018

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Kaasch AJ, Fätkenheuer G, Prinz-Langenohl R, Paulus U, Hellmich M, Weiß V, Jung N, Rieg S, Kern WV, Seifert H; SABATO trial group (with linked authorship to the individuals in the Acknowledgements section). Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial. Trials. 2015 Oct 9;16:450. doi: 10.1186/s13063-015-0973-x.

To Top